2,786 Shares in Encompass Health Co. (NYSE:EHC) Bought by Stevens Capital Management LP

Stevens Capital Management LP acquired a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,786 shares of the company's stock, valued at approximately $257,000.

Several other hedge funds have also recently bought and sold shares of EHC. Raymond James Financial Inc. acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $77,944,000. Point72 Asset Management L.P. boosted its holdings in shares of Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock valued at $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Jennison Associates LLC bought a new position in shares of Encompass Health in the 4th quarter valued at $52,094,000. abrdn plc bought a new position in shares of Encompass Health in the 4th quarter valued at $17,846,000. Finally, Thrivent Financial for Lutherans raised its holdings in shares of Encompass Health by 16.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 888,827 shares of the company's stock worth $82,083,000 after buying an additional 128,331 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Activity at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.10% of the stock is owned by company insiders.

Remove Ads

Encompass Health Trading Down 0.4 %

NYSE:EHC traded down $0.39 during trading hours on Friday, hitting $100.75. 457,600 shares of the company were exchanged, compared to its average volume of 649,885. The company has a fifty day simple moving average of $98.67 and a 200 day simple moving average of $97.38. Encompass Health Co. has a one year low of $78.53 and a one year high of $104.55. The stock has a market capitalization of $10.15 billion, a price-to-earnings ratio of 22.59, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Sell-side analysts expect that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.67%. Encompass Health's payout ratio is 15.25%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. Royal Bank of Canada restated an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health currently has an average rating of "Buy" and a consensus target price of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.